Buy Tibsovo (ivosidenib) Online
$23,691.00Buy Tibsovo (ivosidenib) Online
$23,691.00
Disease Indications: Leukemia, Bile Duct Cancer
Manufacturer: Agios Pharmaceuticals, Inc.
Usage: Oral
Medicine approved by:
Food and Drug Administration (FDA)
Tibsovo (ivosidenib) is designed to treat two conditions: relapsed or refractory acute myeloid leukemia (AML) with an IDH1 mutation, and previously treated, locally advanced or metastatic cholangiocarcinoma (bile duct cancer) with the same mutation.